返回
Burning Rock Biotech Ltd (BNR) 收益
BNR 股价走势图
BNR 收益
Burning Rock Biotech Ltd
$18.57
-2.87%
$-0.55
收盘价：Mar 23, 16:00:00 GMT-4
$18.57
0%
$0
盘前：Mar 24, 08:31:37 GMT-4
最新收益结果： Q3 '22
报告： 2022-11-15
历史收益
季度性
年度
EPS
收入
Earnings FAQ
BNR 最近的每股收益与预期相比如何？
Burning Rock Biotech Ltd BNR 上一季度的收入表现如何？
Burning Rock Biotech Ltd 的收入预期是多少？
Burning Rock Biotech Ltd 的盈利质量评分是多少？
Burning Rock Biotech Ltd 何时发布财报？
Burning Rock Biotech Ltd 的预期收益是多少？
Burning Rock Biotech Ltd 是否超出收益预期？
关键数据
前收盘价
$19.12
开盘价
$18.79
当日区间
$18.5 - $18.79
52周范围
$2.18 - $41.72
交易量
11.0K
平均成交量
25.7K
股息收益率
--
每股收益（TTM）
-1.16
市值
$190.5M
什么是 BNR？
Burning Rock Biotech Ltd. engages in the investment of medical fields. The company is headquartered in Guangzhou, Guangdong and currently employs 674 full-time employees. The company went IPO on 2020-06-12. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.